Straumann Holding AG
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
9.56%
Market Cap
16.06 Bil.
P/E Ratio
41.86
Dividend Yield
1.07 %
Earnings per Share
2.39 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
| ResMed Inc. | 32.17 Bil. | 4.73 Bil. | 27.14 | +36.48 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 112.05 G | 0 Units |
| PRICE DETERMINATION TIME | 06/17/2026 / 05:32:16 PM | |
| DAILY VOLUME (UNITS) | 175 | |
| DAILY HIGH / LOW | 113.2 | 106.05 |
| PREV. DAY'S PRICE | 100.75 | (06/16) |
| CHANGE DAY BEFORE | +11.30 | 11.22 % |
| 52 WEEK HIGH / LOW | 118.3 (07/28) | 79.68 (03/23) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 3.95 | 3.35 | 2.39 | 2.55 | 1.59 |
| DIVIDENDS PER SHARE | 1.27 | 1.10 | 1.07 | 1.00 | 0.88 |
| DIVIDEND YIELD IN % | - | - | 1.07 % | 0.83 % | 0.63 % |
| DIVIDEND GROWTH IN % | - | - | 7.18 % | 14.00 % | 9.77 % |
| PRICE - EARNINGS RATIO | 25.72 | 30.30 | 41.86 | 47.11 | 87.84 |
| PRICE - BOOK RATIO | - | - | 6.90 | 8.93 | 11.77 |
| PRICE - SALES RATIO | - | - | 5.73 | 7.28 | 8.97 |
| PRICE - CASH FLOW RATIO | - | - | 29.52 | 37.65 | 42.79 |
Master Data
| WKN | A3DHHH |
| ISIN | CH1175448666 |
| SYMBOL | QS51 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Straumann |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 159.45 Mil. |
| MARKET CAPITALISATION | 16.06 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.94 % | 9.80 % | 12.62 % | -0.15 % | -9.56 % | - | - | 1.24 % |
| HIGH | 103.60 | 105.60 | 105.60 | 111.05 | 118.30 | - | - | 111.05 |
| LOW | 100.00 | 89.40 | 79.68 | 79.68 | 79.68 | - | - | 79.68 |
Dividend
per share
Company profile
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Western Europe, Sales Central Eastern Europe, Middle East and Africa (CEEMEA), Sales North America (NAM), Sales Asia Pacific (APAC), Sales Latin America (LATAM), and Operations. The Sales Western Europe segment comprises Group’s distribution businesses in Scandinavia, the UK, France, the Benelux countries, Iberia and Italy; implant-borne prosthetics business of Createch, as well as Anthogyr manufacturing plants, a French company that develops and manufactures dental implant systems and CADCAM solutions. The Sales CEEMEA segment comprises the Group's distribution businesses mainly in Germany, Switzerland, Austria, Hungary, the Czech Republic, Russia, Turkey, Croatia, Jordan and South Africa, as well as the business with European, African and Middle Eastern distributors. The Sales NAM segment comprises ClearCorrect’s clear-aligner business and its associated development and production activities. The Sales APAC segment comprises Group’s distribution businesses in the Asia pacific region, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.
Structured products for Straumann Holding AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.